🧬 SinoBioData Academic Portal
Open AccessDOI: 10.12307/2026.21466Original Research

Properties of boron nitride nanosheet-reinforced resin-matrix ceramics

ZHANG Min-di¹,MA Teng¹,SU Qi-long¹,DIAO Kai-xuan¹,REN Guang-hui¹

School of Stomatology, Binzhou Medical University, Yantai 264003, Shandong Province, China; Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai 200050, China; Center for Occlusion, Yantai Stomatological Hospital of Binzhou Medical University, Yantai 264000, Shandong Province, China

Read Executive PreviewQuick FAQ
Properties of boron nitride nanosheet-reinforced resin-matrix ceramics
Graphical Abstract / Figure
Published In
Chinese Journal of Tissue Engineering Research
Published:January 15, 2026Edition:Vol 1903, Issue 31 • pp. 100-112Citation:ZHANG Min-di et al. (2026), Chinese Journal of Tissue Engineering Research
Impact FactorPremier Chinese Biomedical Journal indexed in SinoBioData: Chinese Journal of Tissue Engineering Research (中国组织工程研究).
Sponsored Research Partner

Key Takeaways & Executive Findings

  • • Incorporation of boron nitride nanosheets at 0.5% mass fraction maximally enhanced flexural strength and microhardness of resin-matrix ceramics. • All tested boron nitride nanosheet/resin-matrix ceramics exhibited excellent cytocompatibility with L929 and HUVEC cells (survival >85%). • Wear resistance varied with boron nitride nanosheet content and cycle number; 0.5% provided optimal wear resistance after 120,000 cycles. • Boron nitride nanosheets increased hydrophobicity of resin-matrix ceramics, as indicated by increased water contact angle.
Sponsored Research Highlight

Abstract

BACKGROUND: Boron nitride nanosheets have demonstrated remarkable advantages in enhancing the properties of dental materials. However, the current research on boron nitride nanosheets-reinforced resin-matrix ceramic materials is still in the preliminary exploration stage. OBJECTIVE: To investigate the effect of boron nitride nanosheet addition on the properties of resin-matrix ceramics. METHODS: 60% bisphenol A glycidyl methacrylate and 40% triethylene glycol dimethacrylate were used as the resin matrix, and barium glass powder was used as the inorganic filler. Resin-matrix ceramics were prepared by mixing 83% (mass fraction) of the resin matrix with 17% (mass fraction) of the barium glass powder. Meanwhile, boron nitride nanosheets were added to replace the barium glass powder at mass fractions of 0.3%, 0.5%, 0.7%, and 0.9% to prepare 0.3%, 0.5%, 0.7%, and 0.9% (mass fractions) of boron nitride nanosheet/resin-matrix ceramics, respectively. Resin-matrix ceramics were co-cultured with extracts of 0.3%, 0.5%, 0.7%, and 0.9% boron nitride nanosheet/resin-matrix ceramics and mouse fibroblast L929 cells (or human umbilical vein endothelial cells). CCK-8 assay was used to detect the survival rate of the two cells, and live/dead staining was used to detect L929 cell activity. The wettability, mechanical properties, and wear properties of resin-matrix ceramics and 0.3%, 0.5%, 0.7%, and 0.9% boron nitride nanosheet/resin-matrix ceramics were tested. RESULTS AND CONCLUSION: (1) After co-culture with resin-matrix ceramics and extracts of 0.3%, 0.5%, 0.7%, and 0.9% boron nitride nanosheet/resin-matrix ceramics, the survival rates of L929 cells and human umbilical vein endothelial cells all exceeded 85%, with no obvious cytotoxicity; live/dead staining showed that the extracts of resin-matrix ceramics and 0.3%, 0.5%, 0.7%, and 0.9% boron nitride nanosheet/resin-matrix ceramics did not affect L929 cell activity. (2) With the increase of boron nitride nanosheet mass fraction in the material, the water contact angle of resin-matrix ceramics increased, and the flexural strength and microhardness first increased and then decreased, among which 0.5% boron nitride nanosheet/resin-matrix ceramics had the highest flexural strength and microhardness. After 60,000 cycles, with the increase of boron nitride nanosheet mass fraction, the wear depth and wear volume of resin-matrix ceramics gradually increased; after 120,000 cycles, with the increase of boron nitride nanosheet mass fraction, the wear depth and wear volume of resin-matrix ceramics first decreased and then increased. The results show that appropriate addition of boron nitride nanosheets can significantly improve the comprehensive properties of resin-matrix ceramics.

1. Introduction

Dental restorative materials, as key elements for oral functional reconstruction, must not only possess excellent physicochemical properties to adapt to the complex oral environment [1], but also match the mechanical properties of natural enamel to achieve durable and stable restoration [2]. In recent years, resin-matrix ceramics have been widely used in dental restoration due to their unique performance advantages [3]. These materials combine the processability of traditional resin materials with the high strength of ceramic materials [4], achieving optimized performance. Compositionally, resin-matrix ceramics mainly consist of an organic matrix and inorganic fillers [5]. The addition of inorganic fillers not only significantly enhances the mechanical properties [6] and wear resistance [7] but also effectively reduces polymerization shrinkage [8-9], significantly improving the comprehensive performance and clinical application value of the material in dental restoration [10].

Studies have shown that adding nano- and micron-sized particles to resin-matrix ceramics can effectively enhance the mechanical strength of the material under masticatory load [11]. Boron nitride nanosheets are a new type of two-dimensional nanomaterial with a structure similar to graphene [12], in which the original carbon atoms of graphene are completely replaced by boron and nitrogen atoms arranged in a hexagonal lattice with strong covalent bonds [13]. Compared with graphene and other two-dimensional materials, boron nitride nanosheets possess unique advantages [14]. Their biological inertness stems from stable B-N bonds, which can effectively reduce reactive oxygen species-induced cytotoxicity and inflammatory risks [15-16]. Furthermore, compared with silica particles, boron nitride nanosheets have higher interfacial compatibility and toughening ability [17], while avoiding stress concentration issues caused by silica [18]. These characteristics make boron nitride nanosheets more promising for applications in dental resin composites and ceramic materials [19-20]. Research has proven that adding a small amount of boron nitride nanosheets can significantly enhance the flexural strength and hardness of dental resin composites and dental zirconia materials [21-22]. For example, LI et al. [19] added boron nitride nanosheets to polymethyl methacrylate, increasing its flexural strength by 56.7% and compressive strength by 53%; LEE et al. [23] added boron nitride nanosheets to zirconia, increasing its flexural strength by 27.3% and fracture toughness by 37.5%. These findings fully confirm the significant effectiveness of boron nitride nanosheets as a reinforcing phase in polymer-based and ceramic materials, laying a theoretical and practical foundation for further research.

Given that resin-matrix ceramics are in long-term contact with gingiva and dental pulp, the biocompatibility of the material is particularly critical [24]. Regarding the biocompatibility of boron nitride nanosheets,

SinoBioData Interactive Document Reader
Page 1–5 of Preview
100%
Download Full PDF

Loading authentic research manuscript (Pages 1–5)...

Sponsored Research Partner
Cite This Research Paper
ZHANG Min-di, MA Teng, SU Qi-long, DIAO Kai-xuan, REN Guang-hui (2026). Properties of boron nitride nanosheet-reinforced resin-matrix ceramics. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21466
SinoBioData Academic & Legal Disclaimer

Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.

Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.

Frequently Asked Questions

What is the optimal concentration of boron nitride nanosheets in resin-matrix ceramics?

The study found that 0.5% mass fraction of boron nitride nanosheets provided the highest flexural strength and microhardness, and also optimal wear resistance after 120,000 cycles.

Are boron nitride nanosheet-reinforced resin-matrix ceramics biocompatible?

Yes, all tested concentrations (0.3%, 0.5%, 0.7%, and 0.9%) showed no obvious cytotoxicity, with cell survival rates exceeding 85% for L929 and HUVEC cells.

How does boron nitride nanosheet addition affect the hydrophobicity of resin-matrix ceramics?

The water contact angle increased with increasing boron nitride nanosheet content, indicating enhanced hydrophobicity.

What methods were used to prepare the boron nitride nanosheet-reinforced resin-matrix ceramics?

The ceramics were prepared by ball milling and warm isostatic pressing, with boron nitride nanosheets replacing barium glass powder at various mass fractions.

What are the potential applications of boron nitride nanosheet-reinforced resin-matrix ceramics?

These materials are intended for dental restorative applications such as crowns, inlays, and veneers, due to their improved mechanical properties and biocompatibility.

Recommended Scientific Literature & Research Partners

Related Technical Papers & Translations

Research Paper
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.

Read Abstract & PDF
Research Paper
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.

Read Abstract & PDF
Research Paper
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.

Read Abstract & PDF